To include your compound in the COVID-19 Resource Center, submit it here.

Mesupron: Completed Phase II enrollment

Wilex completed enrollment of 132 patients in a double-blind, international Phase

Read the full 111 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE